Alpha Case Study: Quality Biotech

Alpha Case Study: Quality Biotech

There are some companies and indeed whole industries, where share-tipping is based purely on speculation. Biotechnology is a field where it is very difficult to predict which companies will launch a product that delivers spectacular returns and/or become takeover targets for the big players in global pharma. Relatively young companies listed on the alternative market, often burn through cash in their quest to launch ground-breaking new drugs or medical devices. Added to this, the shares can be thinly traded and the free float restricted, so any set-backs in terms of trial results, regulatory news and contracts, can see magnified falls in share prices.

To continue reading, subscribe to Alpha today

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now